Director, Early Safety Immunology

Boehringer Ingelheim GmbH

Ridgefield (CT)

On-site

USD 200,000 - 316,000

Full time

9 days ago
Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Job summary

Boehringer Ingelheim GmbH seeks a Director of Early Safety Immunology to lead immune safety efforts across discovery, preclinical, and clinical development. The role entails strategic oversight, resource allocation, and collaboration with IU, CPS TAs, CI and Discovery Research to mitigate immune-related safety risks.

The candidate will guide scientists, develop novel models/technologies, and ensure high-quality data interpretation to support portfolio decisions, while mentoring staff and

Qualifications

  • Ph.D. in Immunology or equivalent required.
  • Extensive experience in laboratory-based immune safety assessments and mechanistic derisking studies.
  • Proven leadership and staff development experience, including senior scientists.
  • Ability to operate in dynamic environments and guide teams through ambiguity.
  • Excellent written and verbal communications skills.

Responsibilities

  • Manages a group of approximately 15-25 FTEs conducting immune safety-related toxicology studies.
  • Provides scientific oversight, developing strategy and ensuring delivery of results to senior management.
  • Maintains operational control, staffing, workload, standards and resource distribution.
  • Guides interpretation of computational, molecular, in vitro, cellular and immunotoxicology data for mechanism understanding.
  • Keeps up-to-date with scientific and regulatory areas and identifies opportunities for new work.
  • Ensures modality-driven early safety strategies for innovative immune concepts.
  • Provides recommendations to Global Head, VP and above.
  • Ensures compliance with ICH, FDA, EPA, OSHA and company policies.

Skills

Ph.D. in Immunology
Immunology/toxicology experience
Leadership/people management
Strong communication skills
Onsite with remote flexibility

Education

Ph.D. in Immunology or equivalent

Job description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides an opportunity for all employees to collaborate internationally, offering visibility and the opportunity to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
The primary objective of the Director Early Safety Immunology role is to lead Early Safety immunology, tasked with proactively developing and utilizing novel models/technologies to ensure tailored, modality driven safety evaluations of immune therapeutics during discovery, preclinical and clinical development. The incumbent ensures appropriate assignment of scientists to projects, suitable technology and collaborative investments, and delivery of the highest quality mechanistic data/interpretation to support portfolio decisions. Guiding the professional and personal development of staff is a critical responsibility for this role. The position works closely with the other functional heads within Nonclinical/Early Safety Sciences, CPS TAs, CI and Discovery Research to drive early identification, understanding and mitigation of immune-related safety risks.

Duties & Responsibilities
  • Manages a group of approximately 15-20/20-25 FTEs conducting investigative toxicology studies (focus immune safety) supporting early discovery, preclinical and clinical development; implementing nontraditional approaches to advance/rescue compounds and to predict and/or understand immune mediated toxicities.
  • Provides scientific oversight of Early Safety Immunology, including developing strategy, establishing context (internal & external), evaluating output/reports, and ensuring accurate delivery of results to senior management and project teams.
  • Maintains operational control of functions within Early Safety Immunology, including balancing assignments, monitoring workload, maintaining standards/compliance and distributing resources.
  • Guides interpretation of computational, molecular, in vitro, cellular and immunotoxicology data and supports the utilization of these data for understanding mechanisms of immune safety liabilities, in developing novel biomarkers, and/or in developing predictive & analytical tools.
  • Maintains up-to-date expertise in pertinent scientific and regulatory areas and identifies opportunities/trends to develop and guide new avenues of work.
  • Ensures fit for purpose and modality driven early safety strategies for innovative immune modulating concepts.
  • Provides bottom lines and recommendations to senior management (Global Head, VP & above).
  • Complies with all ICH, FDA, EPA, OSHA and company regulations and policies.
  • Excellent collaboration with a wide range of scientists within the IU and maintaining a network of resources both internally and externally to develop projects/strategies appropriately to achieve critical goals.
Requirements
  • Ph.D. in Immunology or equivalent with roughly ten (10) years’ experience in the pharmaceutical industry required.
  • Extensive experience in laboratory-based immune safety assessments, mechanistic derisking studies, and the ability to lead the scientists engaged in these studies.
  • Well-developed management and supervisory skills, with proven experience in leading and developing staff, including senior scientists.
  • Ability to operate effectively in dynamic, evolving environments and guide teams through ambiguity.
  • Established reputation and/or publication record, preferably in the fields of immunology, toxicology, or cell/molecular biology.
  • Excellent written and verbal communications skills.
  • Onsite/Flex*: This position is site based with flexibility for remote working. Working onsite a minimum of 2-3 days per week is required. Remote working norms will be clarified during the interview process.
Eligibility Requirements
  • Must be legally authorized to work in the United States without restriction.
  • Must be willing to take a drug test and post-offer physical (if required).
  • Must be 18 years of age or older.
Compensation Data

The base salary range for this position is $200,000.00 to $316,000.00 USD. The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law. For an overview of our benefits please

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Director, Early Safety Immunology (Ridgefield, CT, United States, Connecticut)
Director, Early Safety Immunology (Ridgefield, CT, United States, Connecticut)

Biopharma Careers • Ridgefield (CT)

Hybrid
USD 200,000 - 316,000
Director, Early Safety Immunology — Hybrid/Remote
Director, Early Safety Immunology — Hybrid/Remote

Boehringer Ingelheim GmbH • Ridgefield (CT)

On-site
USD 200,000 - 316,000
Executive Director, Experimental Medicine - Immunology (Ridgefield, CT, United States, Connecticut)
Executive Director, Experimental Medicine - Immunology (Ridgefield, CT, United States, Connecticut)

Biopharma Careers • Ridgefield (CT)

On-site
USD 280,000 - 441,000
Competitive compensation
Global exposure
Distinguished Research Fellow- Nonclinical Safety
Distinguished Research Fellow- Nonclinical Safety

Boehringer Ingelheim • Ridgefield (CT)

On-site
USD 200,000 - 316,000
Executive Director, Experimental Medicine - Immunology
Executive Director, Experimental Medicine - Immunology

Boehringer Ingelheim GmbH • Ridgefield (CT)

On-site
USD 280,000 - 441,000
Discretionary bonuses
Relocation assistance
Comprehensive benefits
Immunology Executive Director - Early Clinical Development
Immunology Executive Director - Early Clinical Development

Boehringer Ingelheim • Ridgefield (CT)

On-site
USD 280,000 - 441,000
Director, Immune Safety Immunology – Hybrid
Director, Immune Safety Immunology – Hybrid

Biopharma Careers • Ridgefield (CT)

Hybrid
USD 200,000 - 316,000
Director, Clinical Trial Team Lead - Immunology - 32384
Director, Clinical Trial Team Lead - Immunology - 32384

University Industry Demonstration Partnership • Ridgefield (CT)

On-site
USD 200,000 - 316,000
Senior Principal/ Principal Scientist, Computational Safety (Ridgefield, CT, United States, Connecticut)
Senior Principal/ Principal Scientist, Computational Safety (Ridgefield, CT, United States, Connecticut)

Biopharma Careers • Ridgefield (CT)

On-site
USD 140,000 - 269,000
Senior Principal/ Principal Scientist, Computational Safety
Senior Principal/ Principal Scientist, Computational Safety

Boehringer Ingelheim GmbH • Ridgefield (CT), Northern (KY)

Hybrid
USD 140,000 - 269,000